About MEMS   |   Council   |   Members Centre   |   Membership   |   Contact Us   |   Home
  Member Login     username:     password:           Forgot your password?
  Home » CME » 
President's Message
The Endocrine Directory
Calendar of Events
Announcements & Updates
Breaking News & Reports
Endocrine Modules
Endocrine Update
Combined Clinical Meeting
In the Press
Disease Areas
Healthy Lifestyle
Research Programs
Photo & Video Gallery
Useful Links
Disease Management
arrow Endocrine Update 2016
Section: CME
Theme: Pearls in Practical Endocrinology
Date: 22nd October 2016
Venue: Dewan Batu Bersurat, Muzium Negeri Terengganu
舞ead more...

arrow MEMS Endo Update in KT
Section: CME
MEMS's Endo Updates in KT was held on 22 October 2016.
Theme: Pearls in Practical Endocrinology
舞ead more...

arrow Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes - NEJM
The SGLT2 inhibitor, empagliflozin, significantly reduced deaths among individuals with type 2 diabetes and established cardiovascular disease (CVD) when compared with placebo in what is being heralded as a landmark trial.
舞ead more...

arrow Menopausal hormone therapy association with breast cancer strengthened
In 2002, the Women's Health Initiative (WHI) randomized trial of placebo vs hormone therapy with estrogen and progestin was stopped early because of evidence of harm.1 Sales of combined estrogen-progestin plummeted 32% between the period immediately before the study's release and the analogous period 1 year later, as the WHI trial had shown that hormone therapy increased a woman's risk of breast cancer and myocardial infarction.
舞ead more...

arrow New propylthiouracil warnings change face of hyperthyroid treatment in pregnancy
Untreated hyperthyroidism in pregnancy places the mother and child at an elevated risk for a number of adverse outcomes, including preeclampsia and congestive heart failure. Because radioactive iodine is not a viable option during pregnancy, and surgery is risky, health care professionals are limited to propylthiouracil and methimazole.
舞ead more...

arrow Sodium Glucose Transporter-2 (SGLT-2) Inhibitors: A New Class of Anti-Diabetic Agent
Aretaus, one of the most celebrated of the ancient Greek physicians coined the term "diabetes" when he derived the name for the wasting disease from the Greek word siphon" (diabaino in Ionian Greek, meaning passing through). While the 17th century London physician, Dr Thomas Willis, diagnosed "honeyed" diabetes by sampling the urine of his patients.
舞ead more...


| | | |
© Copyright Malaysian Endocrine & Metabolic Society (MEMS)   2009 - 2016    All rights reserved.
designed & maintained: mobition